Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDs*

By Niculescu Liviu   Li Chunming   Huang Jim   Mallen Sharon  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 729-740

Informa Healthcare

Access to resources Recommend Favorite

The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis

By Ramey Dena R.   Watson Douglas J.   Yu Chang   Bolognese James A.   Curtis Sean P.   Reicin Alise S.  

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 715-722

Informa Healthcare

Access to resources Recommend Favorite

The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials

By Soni Paresh   Shell Briton   Cawkwell Gail   Li Chunming   Ma Hong  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1841-1851

Informa Healthcare

Access to resources Recommend Favorite

Persistence with non-selective NSAIDs and celecoxib among patients with gastroesophageal reflux disease and osteoarthritis or rheumatoid arthritis

By Cryer B.   Luo X.   Assaf A.R.   Sands G.   Mardekian J.  

Current Medical Research and Opinion, Vol. 27, Iss. 2, 2011-02 ,pp. : 295-302

Informa Healthcare

Access to resources Recommend Favorite

Gastroprotection in patients prescribed non-selective NSAIDs, and the risk of related hospitalization

By Koncz T. A.   Lister S. P.   Makinson G. T.  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3405-3412

Informa Healthcare

Access to resources Recommend Favorite